Navigation Links
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
Date:6/2/2008

- Observed Dose-Response Trends Suggest Improved Efficacy with Higher Doses

-

- Dose Escalation Ongoing -

SAN FRANCISCO and CHICAGO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that data from an ongoing Phase 1-2 clinical trial of the Company's novel androgen receptor antagonist, MDV3100, showed encouraging anti-tumor activity as measured by declining serum levels of prostate specific antigen (PSA) and circulating tumor cells (CTC), as well as radiographic disease stabilization, after three months of treatment. An increased number of androgen receptors present on prostate cancer cells is believed to play a major role in the growth of castration-resistant prostate cancer, also known as hormone-refractory prostate cancer. The observed clinical effects of MDV3100 on PSA levels, CTC counts and radiographic disease are consistent with blockade of androgen receptor signaling and inhibition of tumor growth. To date, 90 patients have been enrolled in the trial with enrollment completed at doses up to 240 mg/day. MDV3100 has been well tolerated and dose escalation at 360 mg/day is in progress.

The data were presented at the American Society of Clinical Oncology 2008 Annual Meeting in Chicago in an oral presentation entitled "Phase 1-2 study of MDV3100 in patients (pts) with progressive Castration-Resistant Prostate Cancer (CRPC)" by principal investigator, Howard Scher, M.D., chief of the Genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York.

The ongoing Phase 1-2 trial is an open-label U.S. dose-escalation study enrolling prostate cancer patients
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
2. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
3. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
4. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
5. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
7. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
8. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
9. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
10. Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer
11. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/--V...CompanyfileditsPlanofReorganizationandDisclosureSt...nkruptcyCourtfortheDistrictofDelaware.Ahearingtoco...cheduledforDecember8,2009,withthehearingontheconfi...hePlancallsfortheCompanytopayallclaimsinfull.ThePl...
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire/--Accumetrics,Inc.,...#174;System,thefirstrapidandeasy-to-usediagnostics...ntiplateletagents(e.g.Plavix®andaspirin),anno...metrics,andGregoryJ.Tibbitts,ChiefFinancialOfficer...the21stAnnualPiperJaffrayHealthCareConferencebeing...
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire/--AmbitBiosciencesC...sentationsevaluatingAC220,anovelsecondgenerationFL...ogyAnnualMeeting(ASH)tobeheldinNewOrleans,LA,Decem...fromanongoingclinicalPhaseImonotherapysafetystudyi...non-clinicaldatawillbepresentedevaluatingtheeffect...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Private Care Association of Floridas Elects Jim Mark as Vice President 58579 1Private Care Association of Floridas Elects Jim Mark as Vice President 58579 2Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 1Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 2Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 3Video 3A Worksite Wellness Programs Lower Healthcare Costs Make Employees Healthier 58577 4Heartland Information Services Appoints New Chief Executive Officer 58575 1Heartland Information Services Appoints New Chief Executive Officer 58575 2
(Date:11/24/2009)...YORK,Nov.24/PRNewswire/-- Asyear-endapproaches,ma...taxesthisyearandnext.Tohelpyoutakeadvantageofthese...iorTaxAnalystatThomsonReuters,highlightsthefollowi..., Healthflexiblespendingaccounts(HealthFSAs) ...tytosavetaxesbyplacingfundsintheiremployer,shealth...
(Date:11/24/2009)...ESUCCESS,N.Y.,Nov.24/PRNewswire-USNewswire/--IPROh...ternationalqualitymanagementstandardfocusedonfulfi...ctionandcontinuallyimprovingbusinessperformance.Ce...cationServicesmeansIPRO,sQualityManagementSystem(Q...ationsatitsofficesinLakeSuccessandAlbany,NewYorkas...
(Date:11/24/2009)... Physician recruiting firm LocumTene...staffing, is pleased to announce its agreement wit...ide physicians for locum tenens assignments. , ...ber 24, 2009 -- Physician recruiting firm Locum...cian staffing, is pleased to announce its agreemen...
(Date:11/24/2009)... The molecular cause of inflammatory...ll be presented at the upcoming 2009 Advances in I...; Colitis Foundation’s Clinical & Resear... that may identify a causative mutation for Crohn&...rk, NY (Vocus) November 24, 2009 -- The molecular ...
(Date:11/24/2009)...RISBURG,Pa.,Nov.24/PRNewswire-USNewswire/--Governo...niansat-riskfortheH1N1fluwerevaccinatedduringthewe...lthandlocalhealthdepartments. ,, "Withthefedera...ectionsregardingtheavailabilityofH1N1vaccine,distr...erall,wearepleasedwiththeH1N1vaccinedistributionpr...
Breaking Medicine News(10 mins):Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2
..., Del., Oct. 4 More than 125 leaders,from through...ined together,to support a multi-year, statewide c...the Nation. The campaign, launched by Nemours Heal...,parents, and other leaders to improve the motivat...
...GTON, Oct. 4 Asbestos in the U.S. may,be breathin...an Asbestos in,America Act. Passage in the House i...atty Murray (D-WA) for the past six years, this le...o), and other,asbestos-related diseases, and launc...
...TH, Minn. and REDWOOD CITY, Calif., Oct. 4 /PRNews...oxHollow Technologies, Inc. (Nasdaq: FOXH ),annou...iously announced,merger under which ev3 has now ac... combined to create an organization that,possesses...
...ANCISCO, Oct. 4 Wells Fargo (NYSE: WFC ),today i...ses and,individuals to administer health care bene... Benefit Services to reduce,paperwork and increase...ernet portal, the Commercial Electronic,Office(R) ...
...ce Creates 3rd Largest Health Network, BELLEVUE, ...oup (RHG), owner of one of the Internet,s fastest ...aq: DSCM ), a leading online provider of,health, ...he Revolution Health Network and manage advertisin...
...earchers at the Agency for Science, Technology and...ll Biology (IMCB) have discovered new molecular me...g of how the normally benign Dr. Jekyll-like fungu...life-threatening infections in the mouth, blood an...
Other Medicine News:Health News:Governor Ruth Ann Minner, U.S. Senator Tom Carper, U.S. Representative Mike Castle and Lt. Governor John Carney Join 125 Delaware Community Leaders Endorsing the Campaign to Make Delaware's Kids the Healthiest in the Nation 2Health News:Governor Ruth Ann Minner, U.S. Senator Tom Carper, U.S. Representative Mike Castle and Lt. Governor John Carney Join 125 Delaware Community Leaders Endorsing the Campaign to Make Delaware's Kids the Healthiest in the Nation 3Health News:Asbestos No More: Historic Asbestos Ban Passage Imminent 2Health News:Asbestos No More: Historic Asbestos Ban Passage Imminent 3Health News:Asbestos No More: Historic Asbestos Ban Passage Imminent 4Health News:ev3 and FoxHollow Technologies Announce Completion of Merger 2Health News:ev3 and FoxHollow Technologies Announce Completion of Merger 3Health News:ev3 and FoxHollow Technologies Announce Completion of Merger 4Health News:ev3 and FoxHollow Technologies Announce Completion of Merger 5Health News:Wells Fargo Offers Online Benefit Administration for Business and Individual Healthcare Consumers 2Health News:Wells Fargo Offers Online Benefit Administration for Business and Individual Healthcare Consumers 3Health News:drugstore.com and Revolution Health Group Announce Breakthrough Deal 2Health News:drugstore.com and Revolution Health Group Announce Breakthrough Deal 3Health News:How Candida albicans transforms from its normally benign form into life-threatening form 2
...accurate bedside test for the easy to use Cardiac ...nt of patients with suspected Congestive Heart Fai...acy profit from a test combining speed (measuring...emergency departments Point of Care Testing on ave...
SpeediCath™ Female
...rgery. ,By using Perfluoron, a liquid tool compo...y expand your surgical capabilities. Perfluoron is...d by proliferative vitreoretinopathy, giant retina...ercent pure, Perfluoron is the purest perfluorocar...
Epocrates Dx
Medicine Products: